Cancer Control & Population Sciences
Cancer Therapeutics & Host Response
Cancer Control & Population Sciences
Aduse-Poku L, Karanth SD, Wheeler M, Yang D, Washington C, Hong YR, Manini TM, Fabregas JC, Cheng TD, Braithwaite D. Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors. Cancers (Basel). 2023 Feb 8;15(4):1081. doi: 10.3390/cancers15041081. PubMed PMID: 36831420; PubMed Central PMCID: PMC9953880.
Karanth SD, Akinyemiju T, Walker CJ, Yang D, Migliorati CA, Yoon HS, Hong YR, Washington CJ, Lattimore C, Fredenburg KM, Braithwaite D. The Intersectionality Between Race, Ethnicity, and Residential-level Socioeconomic Status in Disparities of Head and Neck Cancer Outcomes: A SEER study. Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-1167. doi: 10.1158/1055-9965.EPI-22-1167. Online ahead of print. PubMed PMID: 36780193.
McCullum L, Shin J, Xing S, Beekman C, Schuemann J, Hong T, Duda D, Mohan R, Lin S, Correa-Alfonso CM, Domal S, Withrow J, Bolch W, Paganetti H, Grassberger C. Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4D Blood Flow Simulations. Int J Radiat Oncol Biol Phys. 2023 Feb 3:S0360-3016(23)00105-0. doi: 10.1016/j.ijrobp.2023.01.054. Online ahead of print. PubMed PMID: 36739919.
Hochhegger B, Braithwaite D. Beyond the AJR: Should Imaging-Based Risk Assessment Tools Be Used in Lung Cancer Screening? AJR Am J Roentgenol. 2023 Feb 1. doi: 10.2214/AJR.23.29060. Online ahead of print. No abstract available. PubMed PMID: 36722762.
Bagautdinova D, Bacharz KC, Bylund CL, Sae-Hau M, Weiss ES, Rajotte M, Lincoln G, Vasquez TS, Parker ND, Wright KB, Fisher CL. Understanding the Impact of COVID-19 on Chronic Lymphocytic Leukemia (CLL) Caregiving and Related Resource Needs. J Clin Med. 2023 Feb 18;12(4):1648. doi: 10.3390/jcm12041648. PubMed PMID: 36836183; PubMed Central PMCID: PMC9965960.
Bteddini DS, LeLaurin JH, Chi X, Hall JM, Theis RP, Gurka MJ, Lee JH, Mobley EM, Khalil GE, Polansky CJ, Kellner AM, Fahnlander AM, Kelder SH, Fiellin LE, Gutter MS, Shenkman EA, Salloum RG. Mixed methods evaluation of vaping and tobacco product use prevention interventions among youth in the Florida 4-H program. Addict Behav. 2023 Feb 3;141:107637. doi: 10.1016/j.addbeh.2023.107637. Online ahead of print. PubMed PMID: 36753933.
Johnson SB, Bylund CL. Identifying Cancer Treatment Misinformation and Strategies to Mitigate Its Effects With Improved Radiation Oncologist-Patient Communication. Pract Radiat Oncol. 2023 Feb 2:S1879-8500(23)00033-4. doi: 10.1016/j.prro.2023.01.007. Online ahead of print. PubMed PMID: 36736620.
Telisnor G, DeRemer DL, Frimpong E, Agyare E, Allen J, Ricks-Santi L, Han B, George T, Rogers SC. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. J Natl Med Assoc. 2023 Feb 17:S0027-9684(23)00017-2. doi: 10.1016/j.jnma.2023.01.008. Online ahead of print. PubMed PMID: 36801148.
Ilozumba MN, Yaghjyan L, Datta S, Zhao J, Hong CC, Lunetta KL, Zirpoli G, Bandera EV, Palmer JR, Yao S, Ambrosone CB, Cheng TD. mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women’s Circle of Health Study. Cancer Causes Control. 2023 Feb 15. doi: 10.1007/s10552-022-01657-9. Online ahead of print. PubMed PMID: 36790512.
Salloum RG, Bricker JB, Lee JH, Theis RP, Pluta K, Williams MP, Naous J, Mulani SR, Cogle CR, Rubin DA, Fahnlander AM, Nordelo B, Sullivan BM, Bloodworth S, Corbin L, Siler K, Willis D, Carrasquillo O, Dallery J. Comparative effectiveness of mobile health smoking cessation approaches among underserved patients in primary care: Study protocol for the PROMOTE-UP trial. Contemp Clin Trials. 2023 Feb 16;127:107120. doi: 10.1016/j.cct.2023.107120. Online ahead of print. PubMed PMID: 36804046.
Ashouri R, Nguyen B, Archer J, Crispen P, O’Malley P, Su LM, Grajo J, Falzarano SM, Acar Y, Lizdas D, Lampotang S, Brisbane W. Micro-Ultrasound Guided Transperineal Prostate Biopsy: A Clinic-Based Procedure. J Vis Exp. 2023 Feb 3;(192). doi: 10.3791/64772. PubMed PMID: 36805636.
Yaghjyan L, Heng YJ, Baker GM, Rosner BA, Tamimi RM. Associations of alcohol consumption with breast tissue composition. Breast Cancer Res. 2023 Mar 30;25(1):33. doi: 10.1186/s13058-023-01638-z. PubMed PMID: 36998083; PubMed Central PMCID: PMC10061845.
Ilozumba MN, Yaghjyan L, Datta S, Zhao J, Gong Z, Hong CC, Lunetta KL, Zirpoli G, Bandera EV, Palmer JR, Yao S, Ambrosone CB, Cheng TD. mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women’s circle of health study. Breast Cancer Res Treat. 2023 Mar 8. doi: 10.1007/s10549-023-06902-6. Online ahead of print. PubMed PMID: 36882608.
Johnson SB, King AJ, Warner EL, Aneja S, Kann BH, Bylund CL. Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information. JNCI Cancer Spectr. 2023 Mar 1;7(2):pkad015. doi: 10.1093/jncics/pkad015. PubMed PMID: 36929393; PubMed Central PMCID: PMC10020140.
Lampotang S, Lizdas DE, Johnson WT, Mei V, Wakim J, Lou X, DeStephens A, Acar Y, Moy L, Ahmad A, Brisbane W, Stringer T. Development and Validation of a Mixed-Reality Simulator for Reducing Biopsy Core Deviation During Simulated Freehand Systematic Prostate Biopsy. Simul Healthc. 2023 Mar 16. doi: 10.1097/SIH.0000000000000723. Online ahead of print. PubMed PMID: 36976805.
Correa-Alfonso CM, Withrow J, Domal SJ, President B, Dawson RJ, McCullum L, Beekman C, Grassberger C, Paganetti H, Bolch WE. Intra-brain vascular models within the ICRP mesh-type adult reference phantoms for applications to internal dosimetry. Phys Med Biol. 2023 Mar 30. doi: 10.1088/1361-6560/acc926. Online ahead of print. PubMed PMID: 36996844.
Kittelson S, Lo MC, Hagen M, Barker PC, Yacoub RA, Hahn P, Turpening P, Wilkie DJ, Cattier C, Romanello T, Karver SB, Adkins-Dodd B, Shum-Jimenez AS, Weisbrod N, Ledford PA, Ponder-Stansel S. Advancing Palliative Care Systematically Using Education Through a Grassroots Coalition. Palliat Med Rep. 2023 Mar 22;4(1):89-91. doi: 10.1089/pmr.2022.0055. eCollection 2023. No abstract available. PubMed PMID: 36969739; PubMed Central PMCID: PMC10036073.
Saad RK, Maiteh A, Nakkash R, Salloum RG, Chalak A, Abu-Rmeileh NME, Khader Y, Al Nsour M. Monitoring and Combating Waterpipe Tobacco Smoking Through Surveillance and Taxation. JMIR Public Health Surveill. 2023 Mar 23;9:e40177. doi: 10.2196/40177. PubMed PMID: 36951907.
Metts J, Xue W, Gao Z, Ermoian R, Bradley JA, Arnold MA, Dasgupta R, Venkatramani R, Walterhouse D. Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children’s Oncology Group studies from 1997 to 2013: A report from the Children’s Oncology Group. Cancer. 2023 Mar 1. doi: 10.1002/cncr.34723. Online ahead of print. PubMed PMID: 36857314.
Santos FCD, Snigurska UA, Keenan GM, Lucero RJ, Modave F. Clinical Decision Support Systems for Palliative Care Management: A Scoping Review. J Pain Symptom Manage. 2023 Mar 16:S0885-3924(23)00423-2. doi: 10.1016/j.jpainsymman.2023.03.006. Online ahead of print. PubMed PMID: 36933748.
Guo Y, Bian J, Chen Z, Fishe JN, Zhang D, Braithwaite D, George TJ, Shenkman EA, Licht JD. Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States. Cancer Med. 2023 Mar 31. doi: 10.1002/cam4.5875. Online ahead of print. PubMed PMID: 36999938.
Altshuler E, Franke AJ, Skelton WP 4th, Feely M, Wang Y, Lee JH, Read T, Terracina K, Lou XY, Dai Y, George TJ. Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer. Clin Colorectal Cancer. 2023 Mar;22(1):153-159. doi: 10.1016/j.clcc.2022.09.004. Epub 2022 Sep 30. PubMed PMID: 36319582.
Guidry JPD, Miller CA, Perrin PB, Carlyle KE, Savage MW, Sheppard VB, Fuemmeler BF. Pandemic coping and COVID-19 preventive behaviors among cancer survivors. Patient Educ Couns. 2023 Mar 23;112:107716. doi: 10.1016/j.pec.2023.107716. Online ahead of print. PubMed PMID: 37004503.
Chu PW, Kofler C, Mahendra M, Wang Y, Chu CA, Stewart C, Delman BN, Haas B, Lee C, Bolch WE, Smith-Bindman R. Dose length product to effective dose coefficients in children. Pediatr Radiol. 2023 Mar 16. doi: 10.1007/s00247-023-05638-1. Online ahead of print. PubMed PMID: 36922419.
Nguyen OT, Mason A, Khanna N, Charles D, Naso C, Hong YR, Sprow O, Alishahi Tabriz A, Turner K, Spiess P, Patel KB. Patient and caregiver experience with telehealth for surgical cancer care: A qualitative study. J Surg Oncol. 2023 Mar 8. doi: 10.1002/jso.27228. Online ahead of print. PubMed PMID: 36883752.
Pather K, Mobley EM, Guerrier C, Esma R, Awad ZT. A Comparison of Clinical and Cost Outcomes After Pancreatectomies at a Safety-net Hospital using a National Registry. Surg Laparosc Endosc Percutan Tech. 2023 Mar 20. doi: 10.1097/SLE.0000000000001163. Online ahead of print. PubMed PMID: 36971522.
Nguyen OT, Turner K, Charles D, Sprow O, Perkins R, Hong YR, Islam JY, Khanna N, Alishahi Tabriz A, Hallanger-Johnson J, Bickel Young J, Moore CE. Implementing Digital Scribes to Reduce Electronic Health Record Documentation Burden Among Cancer Care Clinicians: A Mixed-Methods Pilot Study. JCO Clin Cancer Inform. 2023 Mar;7:e2200166. doi: 10.1200/CCI.22.00166. PubMed PMID: 36972488.
Cancer Therapeutics & Host Response
Von Roemeling C, Doonan BP, Klippel K, Schultz D, Hoang-Minh L, Trivedi V, Li C, Russell R, Kanumuri RS, Sharma A, Tun HW, Mitchell D. Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases. Clin Cancer Res. 2023 Feb 7:CCR-22-1682. doi: 10.1158/1078-0432.CCR-22-1682. Online ahead of print. PubMed PMID: 36749885.
Telisnor G, DeRemer DL, Frimpong E, Agyare E, Allen J, Ricks-Santi L, Han B, George T, Rogers SC. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. J Natl Med Assoc. 2023 Feb 17:S0027-9684(23)00017-2. doi: 10.1016/j.jnma.2023.01.008. Online ahead of print. PubMed PMID: 36801148.
Ramnaraign B, Sartor O. PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials. Oncologist. 2023 Feb 18:oyac279. doi: 10.1093/oncolo/oyac279. Online ahead of print. PubMed PMID: 36806966.
Gupta S, Dai Y, Chen Z, Winestone LE, Teachey DT, Bona K, Aplenc R, Rabin KR, Zweidler-McKay P, Carroll AJ, Heerema NA, Gastier-Foster J, Borowitz MJ, Wood BL, Maloney KW, Mattano LA Jr, Larsen EC, Angiolillo AL, Burke MJ, Salzer WL, Winter SS, Brown PA, Guest EM, Dunsmore KP, Kairalla JA, Winick NJ, Carroll WL, Raetz EA, Hunger SP, Loh ML, Devidas M. Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children’s Oncology Group cohort trials. Lancet Haematol. 2023 Feb;10(2):e129-e141. doi: 10.1016/S2352-3026(22)00371-4. PubMed PMID: 36725118; PubMed Central PMCID: PMC9951049.
Pinto N, Naranjo A, Ding X, Zhang FF, Hibbitts E, Kennedy R, Tibbetts R, Wong-Michalak S, Craig DW, Manojlovic Z, Hogarty MD, Kreissman S, Bagatell R, Irwin MS, Park JR, Asgharzadeh S. Impact of Genomic and Clinical Factors on Outcome of Children >/=18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification. Clin Cancer Res. 2023 Feb 7:CCR-22-3032. doi: 10.1158/1078-0432.CCR-22-3032. Online ahead of print. PubMed PMID: 36749880.
Bhardwaj M, Cui Z, Daniel Hankore E, Moonschi FH, Saghaeiannejad Esfahani H, Kalkreuter E, Gui C, Yang D, Phillips GN Jr, Thorson JS, Shen B, Van Lanen SG. A discrete intermediate for the biosynthesis of both the enediyne core and the anthraquinone moiety of enediyne natural products. Proc Natl Acad Sci U S A. 2023 Feb 28;120(9):e2220468120. doi: 10.1073/pnas.2220468120. Epub 2023 Feb 21. PubMed PMID: 36802426.
Erbe AK, Diccianni MB, Mody R, Naranjo A, Zhang FF, Birstler J, Kim K, Feils AS, Hung JT, London WB, Shulkin BL, Mathew V, Parisi MT, Servaes S, Asgharzadeh S, Maris JM, Park J, Yu AL, Sondel PM, Bagatell R. KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group. J Immunother Cancer. 2023 Feb;11(2):e006530. doi: 10.1136/jitc-2022-006530. PubMed PMID: 36822669; PubMed Central PMCID: PMC9950969.
DiVita Dean B, Wildes T, Dean J, Yegorov O, Yang C, Shin D, Francis C, Figg JW, Sebastian M, Font LF, Jin D, Reid A, Moore G, Fernandez B, Wummer B, Kuizon C, Mitchell D, Flores CT. Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis. J Immunother Cancer. 2023 Feb;11(2):e004805. doi: 10.1136/jitc-2022-004805. PubMed PMID: 36750252; PubMed Central PMCID: PMC9906384.
Pei J, Xiao Y, Liu X, Hu W, Sobh A, Yuan Y, Zhou S, Hua N, Mackintosh SG, Zhang X, Basso KB, Kamat M, Yang Q, Licht JD, Zheng G, Zhou D, Lv D. Piperlongumine conjugates induce targeted protein degradation. Cell Chem Biol. 2023 Feb 16;30(2):203-213.e17. doi: 10.1016/j.chembiol.2023.01.004. Epub 2023 Feb 6. PubMed PMID: 36750097.
Geng H, Liao Z, Nguyen QN, Berman AT, Robinson C, Wu A, Nichols RC Jr, Willers H, Mohammed N, Mohindra P, Xiao Y. Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study. Cancers (Basel). 2023 Feb 5;15(4):1014. doi: 10.3390/cancers15041014. PubMed PMID: 36831358; PubMed Central PMCID: PMC9953775.
Cao M, Yang D, Adhikari A, Ye F, Zheng C, Yan W, Meng S, Su P, Shen B. Neogrisemycin, a Trisulfide-Bridged Angucycline, Produced upon Expressing the Thioangucycline Biosynthetic Gene Cluster in Streptomyces albus J1074. Org Lett. 2023 Feb 17;25(6):961-965. doi: 10.1021/acs.orglett.2c04303. Epub 2023 Feb 3. PubMed PMID: 36735280.
Hwang E, Gaito S, France A, Crellin AM, Thwaites DI, Ahern V, Indelicato D, Timmermann B, Smith E. Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group. Clin Oncol (R Coll Radiol). 2023 Feb 16:S0936-6555(23)00056-0. doi: 10.1016/j.clon.2023.02.009. Online ahead of print. PubMed PMID: 36813694.
Gaito S, Hwang EJ, France A, Aznar MC, Burnet N, Crellin A, Holtzman AL, Indelicato DJ, Timmerman B, Whitfield GA, Smith E. Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group. Clin Oncol (R Coll Radiol). 2023 Feb 9:S0936-6555(23)00048-1. doi: 10.1016/j.clon.2023.01.024. Online ahead of print. PubMed PMID: 36804292.
Iqbal A, Khan A, Hughes S, George TJ, Tan S, Garcia-Chavez H, Read T. Validation of a pelvic surgery difficulty risk model to predict difficult pelvic dissection and poor outcomes. Surgery. 2023 Feb 15:S0039-6060(22)01083-2. doi: 10.1016/j.surg.2022.12.023. Online ahead of print. PubMed PMID: 36801077.
Lee J, Wickes BL, Fu J, Brockman NE, Garg H, Jobin C, Johson-Pais T, Leach R, Lai Z, Liss MA. Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer. Prostate. 2023 Feb 26. doi: 10.1002/pros.24500. Online ahead of print. PubMed PMID: 36842100.
Campbell K, Kao PC, Naranjo A, Kamijo T, Ramanujachar R, London WB, DuBois SG. Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer. 2023 Feb;70(2):e30054. doi: 10.1002/pbc.30054. Epub 2022 Oct 31. PubMed PMID: 36316811.
Witek ME, Morris CG, Alexander GS, Dontu P, Koroulakis AI, Regine WF, Mendenhall WM. Multi-institutional study of clinical outcomes of patients with head and neck cancer presenting with cN3 disease. Head Neck. 2023 Feb 28. doi: 10.1002/hed.27326. Online ahead of print. PubMed PMID: 36855018.
Anyidoho PA, Verschraegen CF, Markham MJ, Alberts S, Sweetenham J, Cameron K, Abu Hejleh T. Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer. JCO Oncol Pract. 2023 Feb 13:OP2200712. doi: 10.1200/OP.22.00712. Online ahead of print. PubMed PMID: 36780583.
Gracie J, Fortune EC 4th, Morris CG, Leach DF 3rd, Mendenhall WM. Radiation Treatment for Cancer of the Anal Margin. Am J Clin Oncol. 2023 Feb 22. doi: 10.1097/COC.0000000000000986. Online ahead of print. PubMed PMID: 36820471.
Wang CY, Vouri SM, Park H, Heldermon CD, Brown JD. Comparative effectiveness of pegfilgrastim biosimilars vs originator for prevention of febrile neutropenia: A retrospective cohort study. J Manag Care Spec Pharm. 2023 Feb;29(2):119-127. doi: 10.18553/jmcp.2023.29.2.119. PubMed PMID: 36705287.
Salloum RG, Bricker JB, Lee JH, Theis RP, Pluta K, Williams MP, Naous J, Mulani SR, Cogle CR, Rubin DA, Fahnlander AM, Nordelo B, Sullivan BM, Bloodworth S, Corbin L, Siler K, Willis D, Carrasquillo O, Dallery J. Comparative effectiveness of mobile health smoking cessation approaches among underserved patients in primary care: Study protocol for the PROMOTE-UP trial. Contemp Clin Trials. 2023 Feb 16;127:107120. doi: 10.1016/j.cct.2023.107120. Online ahead of print. PubMed PMID: 36804046.
Whiteway SL, Weiss AR, Ahmed SK, Allen-Rhoades WA, Avutu V, Cardona K, Davis LE, Davis EJ, Indelicato DJ, Isakoff MS, Janeway KA, Livingston JA, Patel SR, Reed DR, Riedel RF, Thornton KA, Kopp LM. Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group. J Adolesc Young Adult Oncol. 2023 Feb 1. doi: 10.1089/jayao.2022.0179. Online ahead of print. No abstract available. PubMed PMID: 36724495.
Ashouri R, Nguyen B, Archer J, Crispen P, O’Malley P, Su LM, Grajo J, Falzarano SM, Acar Y, Lizdas D, Lampotang S, Brisbane W. Micro-Ultrasound Guided Transperineal Prostate Biopsy: A Clinic-Based Procedure. J Vis Exp. 2023 Feb 3;(192). doi: 10.3791/64772. PubMed PMID: 36805636.
Riner AN, Freudenberger DC, Herremans KM, Vudatha V, Neal DW, George TJ, Trevino JG. Call to Action: Overcoming Enrollment Disparities in Cancer Clinical Trials with Modernized Eligibility Criteria. JNCI Cancer Spectr. 2023 Feb 21:pkad009. doi: 10.1093/jncics/pkad009. Online ahead of print. PubMed PMID: 36806713.
Mallah H, Altshuler E, Ramnaraign B, Khawaja A. Pneumocystis jirovecii pneumonia in a patient treated with trastuzumab-deruxtecan. BMJ Case Rep. 2023 Feb 20;16(2):e253647. doi: 10.1136/bcr-2022-253647. PubMed PMID: 36805876; PubMed Central PMCID: PMC9943902.
Thomas M, Li J, King K, Persaud AK, Duah E, Vangundy Z, Hofmeister CC, Lamba JK, Tan AC, Fridley BL, Poi MJ, Seligson ND. PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplant. Haematologica. 2023 Mar 2. doi: 10.3324/haematol.2022.282399. Online ahead of print. PubMed PMID: 36861411.
Altshuler E, Franke AJ, Skelton WP 4th, Feely M, Wang Y, Lee JH, Read T, Terracina K, Lou XY, Dai Y, George TJ. Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer. Clin Colorectal Cancer. 2023 Mar;22(1):153-159. doi: 10.1016/j.clcc.2022.09.004. Epub 2022 Sep 30. PubMed PMID: 36319582.
Walentynowicz KA, Engelhardt D, Cristea S, Yadav S, Onubogu U, Salatino R, Maerken M, Vincentelli C, Jhaveri A, Geisberg J, McDonald TO, Michor F, Janiszewska M. Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma. Cell Rep. 2023 Mar 28;42(3):112235. doi: 10.1016/j.celrep.2023.112235. Epub 2023 Mar 14. PubMed PMID: 36920905.
Dhakal D, Kallifidas D, Chen M, Kokkaliari S, Chen QY, Paul VJ, Ding Y, Luesch H. Heterologous Production of the C33-C45 Polyketide Fragment of Anticancer Apratoxins in a Cyanobacterial Host. Org Lett. 2023 Mar 24. doi: 10.1021/acs.orglett.3c00462. Online ahead of print. PubMed PMID: 36961224.
Ozer M, Goksu SY, Akagunduz B, George A, Sahin I. Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials. Cancers (Basel). 2023 Mar 16;15(6):1808. doi: 10.3390/cancers15061808. PubMed PMID: 36980692; PubMed Central PMCID: PMC10046758.
Larkin T, Kashif R, Elsayed AH, Greer B, Mangrola K, Raffiee R, Nguyen N, Shastri V, Horn B, Lamba JK. Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO Precis Oncol. 2023 Mar;7:e2200580. doi: 10.1200/PO.22.00580. PubMed PMID: 36952646.
Holtzman AL, Dagan R, Mendenhall WM. Proton Radiotherapy for Skull-Base Malignancies: Imaging Considerations of Radiotherapy and Complications. Oral Maxillofac Surg Clin North Am. 2023 Mar 31:S1042-3699(23)00005-5. doi: 10.1016/j.coms.2023.02.003. Online ahead of print. PubMed PMID: 37005171.
Ajayi TO, Liu S, Rosen C, Rinaldi-Ramos CM, Allen KD, Sharma B. Application of magnetic particle imaging to evaluate nanoparticle fate in rodent joints. J Control Release. 2023 Mar 10;356:347-359. doi: 10.1016/j.jconrel.2023.02.038. Online ahead of print. PubMed PMID: 36868518.
Shan G. Promising zone two-stage design for a single-arm study with binary outcome. Stat Methods Med Res. 2023 Mar 30:9622802231164737. doi: 10.1177/09622802231164737. Online ahead of print. PubMed PMID: 36998163.
Schore RJ, Angiolillo AL, Kairalla JA, Devidas M, Rabin KR, Zweidler-McKay P, Borowitz MJ, Wood B, Carroll AJ, Heerema NA, Relling MV, Hitzler J, Kadan-Lottick NS, Maloney K, Wang C, Carroll WL, Winick NJ, Raetz EA, Loh ML, Hunger SP. Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932. Leukemia. 2023 Mar 25. doi: 10.1038/s41375-023-01870-8. Online ahead of print. No abstract available. PubMed PMID: 36966262.
Robinson BW, Kairalla JA, Devidas M, Carroll AJ, Harvey RC, Heerema NA, Willman CL, Ball AR, Woods EC, Ballantyne NC, Urtishak KA, Behm FG, Reaman GH, Hilden JM, Camitta BM, Winick NJ, Pullen J, Carroll WL, Hunger SP, Dreyer ZE, Felix CA. KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children’s Oncology Group P9407 trial study. Haematologica. 2023 Mar 2. doi: 10.3324/haematol.2022.281552. Online ahead of print. PubMed PMID: 36861410.
Zhang X, Han Q, Hou R, Xu L, Zhang W, Xing C, Xue L, Zhuang C. Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway. J Med Chem. 2023 Mar 12. doi: 10.1021/acs.jmedchem.3c00197. Online ahead of print. PubMed PMID: 36908007.
Guo Y, Bian J, Chen Z, Fishe JN, Zhang D, Braithwaite D, George TJ, Shenkman EA, Licht JD. Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States. Cancer Med. 2023 Mar 31. doi: 10.1002/cam4.5875. Online ahead of print. PubMed PMID: 36999938.
Roehrig A, Indelicato DJ, Paulino AC, Ermoian R, Hartsell W, Perentesis J, Hill-Kayser C, Lee JY, Laack NN, Mangona V, MacEwan I, Eaton BR, Gallotto S, Bajaj BVM, Aridgides PD, Yock TI. Radiotherapy for Atypical Teratoid/=Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR). J Neurooncol. 2023 Mar 23. doi: 10.1007/s11060-023-04296-5. Online ahead of print. PubMed PMID: 36951945.
Murphy JD, Shiomitsu K, Milner RJ, Lejeune A, Ossiboff RJ, Gell JC, Axiak-Bechtel S. Characterization of expression and prognostic implications of transforming growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma. Vet Immunol Immunopathol. 2023 Mar;257:110560. doi: 10.1016/j.vetimm.2023.110560. Epub 2023 Feb 13. PubMed PMID: 36804838.
Nguyen DT, Pedro DI, Pepe A, Rosa JG, Bowman JI, Trachsel L, Golde GR, Suzuki I, Lavrador JM, Nguyen NTY, Kis MA, Smolchek RA, Diodati N, Liu R, Phillpot SR, Webber AR, Castillo P, Sayour EJ, Sumerlin BS, Sawyer WG. Bioconjugation of COL1 protein on liquid-like solid surfaces to study tumor invasion dynamics. Biointerphases. 2023 Mar 10;18(2):021001. doi: 10.1116/6.0002083. PubMed PMID: 36898958; PubMed Central PMCID: PMC10008099.
Chakraborty R, Yi J, Rybicki L, Preussler J, Deol A, Loren A, Savani B, Jim HSL, Cerny J, Reynolds J, Whitten J, Wingard JR, McGuirk JP, Uberti J, Khera N, Stiff P, Jaglowski SM, Hashmi S, Holtan SG, Devine S, Hahn T, Whalen VL, Saber W, Wood W, Baker KS, Syrjala K, Majhail NS. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Transplant Cell Ther. 2023 Mar 2:S2666-6367(23)01102-8. doi: 10.1016/j.jtct.2023.02.011. Online ahead of print. PubMed PMID: 36870388.
Mechanisms of Oncogenesis
Atyeo N, Chae MY, Toth Z, Sharma A, Papp B. Kaposi’s Sarcoma-Associated Herpesvirus Immediate Early Proteins Trigger FOXQ1 Expression in Oral Epithelial Cells, Engaging in a Novel Lytic Cycle-Sustaining Positive Feedback Loop. J Virol. 2023 Feb 23:e0169622. doi: 10.1128/jvi.01696-22. Online ahead of print. PubMed PMID: 36815831.
Chalfant V, Riveros C, Singh P, Shukla S, Balaji N, Balaji KC. Potential role for protein kinase D inhibitors in prostate cancer. J Mol Med (Berl). 2023 Feb 27. doi: 10.1007/s00109-023-02298-4. Online ahead of print. PubMed PMID: 36843036.
Von Roemeling C, Doonan BP, Klippel K, Schultz D, Hoang-Minh L, Trivedi V, Li C, Russell R, Kanumuri RS, Sharma A, Tun HW, Mitchell D. Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases. Clin Cancer Res. 2023 Feb 7:CCR-22-1682. doi: 10.1158/1078-0432.CCR-22-1682. Online ahead of print. PubMed PMID: 36749885.
Pei J, Xiao Y, Liu X, Hu W, Sobh A, Yuan Y, Zhou S, Hua N, Mackintosh SG, Zhang X, Basso KB, Kamat M, Yang Q, Licht JD, Zheng G, Zhou D, Lv D. Piperlongumine conjugates induce targeted protein degradation. Cell Chem Biol. 2023 Feb 16;30(2):203-213.e17. doi: 10.1016/j.chembiol.2023.01.004. Epub 2023 Feb 6. PubMed PMID: 36750097.
Grams TR, Edwards TG, Bloom DC. HSV-1 LAT Promoter Deletion Viruses Exhibit Strain-Specific and LAT-Dependent Epigenetic Regulation of Latent Viral Genomes in Human Neurons. J Virol. 2023 Feb 28;97(2):e0193522. doi: 10.1128/jvi.01935-22. Epub 2023 Feb 1. PubMed PMID: 36722973; PubMed Central PMCID: PMC9972990.
Karanth SD, Akinyemiju T, Walker CJ, Yang D, Migliorati CA, Yoon HS, Hong YR, Washington CJ, Lattimore C, Fredenburg KM, Braithwaite D. The Intersectionality Between Race, Ethnicity, and Residential-level Socioeconomic Status in Disparities of Head and Neck Cancer Outcomes: A SEER study. Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-1167. doi: 10.1158/1055-9965.EPI-22-1167. Online ahead of print. PubMed PMID: 36780193.
Ilozumba MN, Yaghjyan L, Datta S, Zhao J, Hong CC, Lunetta KL, Zirpoli G, Bandera EV, Palmer JR, Yao S, Ambrosone CB, Cheng TD. mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women’s Circle of Health Study. Cancer Causes Control. 2023 Feb 15. doi: 10.1007/s10552-022-01657-9. Online ahead of print. PubMed PMID: 36790512.
Ashouri R, Nguyen B, Archer J, Crispen P, O’Malley P, Su LM, Grajo J, Falzarano SM, Acar Y, Lizdas D, Lampotang S, Brisbane W. Micro-Ultrasound Guided Transperineal Prostate Biopsy: A Clinic-Based Procedure. J Vis Exp. 2023 Feb 3;(192). doi: 10.3791/64772. PubMed PMID: 36805636.
Combs LR, Combs J, McKenna R, Toth Z. Protein Degradation by Gammaherpesvirus RTAs: More Than Just Viral Transactivators. Viruses. 2023 Mar 11;15(3):730. doi: 10.3390/v15030730. PubMed PMID: 36992439; PubMed Central PMCID: PMC10055789. https://pubmed.ncbi.nlm.nih.gov/36992439
Guo Y, Bian J, Chen Z, Fishe JN, Zhang D, Braithwaite D, George TJ, Shenkman EA, Licht JD. Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States. Cancer Med. 2023 Mar 31. doi: 10.1002/cam4.5875. Online ahead of print. PubMed PMID: 36999938. https://pubmed.ncbi.nlm.nih.gov/36999938
Tamashiro R, Strange L, Schnackenberg K, Santos J, Gadalla H, Zhao L, Li EC, Hill E, Hill B, Sidhu GS, Kirst M, Walker C, Wang GP. Smoking-induced subgingival dysbiosis precedes clinical signs of periodontal disease. Sci Rep. 2023 Mar 7;13(1):3755. doi: 10.1038/s41598-023-30203-z. PubMed PMID: 36882425; PubMed Central PMCID: PMC9992395.
Getu AA, Tigabu A, Zhou M, Lu J, Fodstad O, Tan M. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Mol Cancer. 2023 Mar 2;22(1):43. doi: 10.1186/s12943-023-01751-9. PubMed PMID: 36859240; PubMed Central PMCID: PMC9979440.
Chen Z, Zhou K, Xue J, Small A, Xiao G, Nguyen LXT, Zhang Z, Prince E, Weng H, Huang H, Zhao Z, Qing Y, Shen C, Li W, Han L, Tan B, Su R, Qin H, Li Y, Wu D, Gu Z, Ngo VN, He X, Chao J, Leung K, Wang K, Dong L, Qin X, Cai Z, Sheng Y, Chen Y, Wu X, Zhang B, Shi Y, Marcucci G, Qian Z, Xu M, Muschen M, Chen J, Deng X. Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia. Sci Transl Med. 2023 Mar 29;15(689):eabq8513. doi: 10.1126/scitranslmed.abq8513. Epub 2023 Mar 29. PubMed PMID: 36989375.
Hanley RP, Nie DY, Tabor JR, Li F, Sobh A, Xu C, Barker NK, Dilworth D, Hajian T, Gibson E, Szewczyk MM, Brown PJ, Barsyte-Lovejoy D, Herring LE, Wang GG, Licht JD, Vedadi M, Arrowsmith CH, James LI. Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2. J Am Chem Soc. 2023 Mar 28. doi: 10.1021/jacs.3c01421. Online ahead of print. PubMed PMID: 36976643.
Katsushima K, Pokhrel R, Mahmud I, Yuan M, Murad R, Baral P, Zhou R, Chapagain P, Garrett T, Stapleton S, Jallo G, Bettegowda C, Raabe E, Wechsler-Reya RJ, Eberhart CG, Perera RJ. The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas. Acta Neuropathol Commun. 2023 Mar 10;11(1):38. doi: 10.1186/s40478-023-01521-0. PubMed PMID: 36899402; PubMed Central PMCID: PMC10007801.
Mondal A, Swapna GVT, Lopez MM, Klang L, Hao J, Ma L, Roth MJ, Montelione GT, Perez A. Structure Determination of Challenging Protein-Peptide Complexes Combining NMR Chemical Shift Data and Molecular Dynamics Simulations. J Chem Inf Model. 2023 Mar 29. doi: 10.1021/acs.jcim.2c01595. Online ahead of print. PubMed PMID: 36988562.
Richter S, Garrett TJ, Bechmann N, Clifton-Bligh RJ, Ghayee HK. Metabolomics in paraganglioma: applications and perspectives from genetics to therapy. Endocr Relat Cancer. 2023 Mar 1:ERC-22-0376. doi: 10.1530/ERC-22-0376. Online ahead of print. PubMed PMID: 36897220.
Ilozumba MN, Yaghjyan L, Datta S, Zhao J, Gong Z, Hong CC, Lunetta KL, Zirpoli G, Bandera EV, Palmer JR, Yao S, Ambrosone CB, Cheng TD. mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women’s circle of health study. Breast Cancer Res Treat. 2023 Mar 8. doi: 10.1007/s10549-023-06902-6. Online ahead of print. PubMed PMID: 36882608.
Cheng TD, Zhang R, Gong Z, Qin B, Cannioto RA, Datta S, Zhang W, Omilian AR, Yao S, Khoury T, Hong CC, Bandera EV, Ambrosone CB. Association Between Recreational Physical Activity and mTOR Signaling Pathway Protein Expression in Breast Tumor Tissue. Cancer Res Commun. 2023 Mar 7;3(3):395-403. doi: 10.1158/2767-9764.CRC-22-0405. eCollection 2023 Mar. PubMed PMID: 36895729; PubMed Central PMCID: PMC9990525.